Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding CalciMedica, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CALC: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3031+1
Shares3.73M3.57M−157.3K (−4.2%)
Value$5.93M$10.9M+$5.02M (+84.7%)

New holders (7)

Institutions that held CalciMedica, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CALC in Q3 2025
InstitutionSharesValue% of portfolio
Stonehage Fleming Financial Services Holdings Ltd53,703$165.2K0.00%
Sheets Smith Investment Management51,100$157.2K0.10%
Summit Financial, LLC25,092$77.3K0.00%
XTX Topco Ltd15,345$46.3K0.00%
Rockefeller Capital Management L.P.10,000$30.8K0.00%
Citigroup Inc4,927$15.2K0.00%
Barclays PLC57$1750.00%

Sold out (6)

Institutions that held CalciMedica, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CALC in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Wealthedge Investment Advisors, LLC87,468$139.9K
Stonepine Capital Management, LLC85,000$136.0K
CI Private Wealth, LLC38,000$60.8K
Weaver Consulting Group13,393$21.4K
FMR LLC536$820
Federation des caisses Desjardins du Quebec200$320